tirzepatide lawsuit fda Weight loss drug lawsuit: Mounjaro maker files suit over compounded products FDA says shortage of GLP-1

In the states where we are licensed, our providers can prescribe FDA-approved weight loss medications (including GLP-1 agonists) if you meet the medical criteria

No, the effects of Semaglutide, such as appetite suppression and weight loss, do not last after you stop taking the medicine

Ongoing monitoring and follow-up visits are an important part of the program

A review of the studies reported supporting data of TAs effectiveness in lightening dyschromia

Both medications have the same active ingredient, an injectable originally meant for the management of Type-2 diabetics that also happens to be a potent appetite regulator

- October 28, 2025) - Mblue Labs, a University of Maryland biotechnology spin-out and creator of patented skincare brand Bluelene, today announced the launch of Fit+Firm Serum Advanced Skin Density Renewal Serum , the first clinically tested skincare innovation specifically designed to counteract skin aging associated with GLP-1 medical weight-loss treatments